胡容，教授，博士生导师。2005年毕业于美国新泽西州立大学（RutgersUniversity）并获得药学博士学位。2008年作为特聘教授引进。
研究方向为肿瘤药理学，研究领域主要是：1）非可控性炎症恶性转化：分子机制研究；2）肿瘤化学预防：从天然产物中寻找新型化学预防药物；3）药物新靶点的发现和验证：利用化学小分子化合物探针，发现抗炎抗肿瘤相关药物作用靶点并研究其作用机制；4）肿瘤干细胞与肿瘤多药耐药。
获得江苏省“杰出青年科学基金”，教育部新世纪优秀人才支持计划，江苏省333人才工程等人才计划资助。近年来承担国家自然科学基金、江苏省自然科学基金、国家新药创制重大专项、国家863项目等多项重大科研项目，发表相关SCI论文30余篇。
代表性论著：
1.YangX,ZhangF,WangY,CaiM,WangQ,Guo,QL,LiZY,HuR*.OroxylinAinhibitscolitis-associatedcarcinogenesisviamodulatingtheIL-6/STAT3signalingpathway.InflammBowelDis.2013Aug;19(9):1990-2000.
2.ZhongY,ZhangF,SunZ,ZhouW,LiZY,YouQD,GuoQL,HuR*.DrugresistanceassociateswithactivationofNrf2inMCF-7/DOXcells,andwogoninreversesitbydown-regulatingNrf2-mediatedcellulardefenseresponse.MolCarcinog.2012May16.[Epubaheadofprint]
3.XiM,SunZ,SunH,JiangJ,WangY,ZhangM,ZhuJ,JiaJ,XuL,JiangZ,XueX,YeM,YangX,GaoY,TaoL,GuoX,XuX,GuoQ,ZhangX,HuR*,YouQ.3-aroylmethylene-2,3,6,7-tetrahydro-1H-pyrazino[2,1-a]isoquinolin-4(11bH)-onesaspotentNrf2/AREinducersinhumancancercellsandAOM-DSStreatedmice.JMedChem.2013Sep22.[Epubaheadofprint]
4.WangY,ZhangY,QianC,CaiM,LiY,LiZ,YouQ,WangQ,HuR*,GuoQ.GSK3β/β-cateninsignalingiscorrelatedwiththedifferentiationofgliomacellsinducedbywogonin.ToxicolLett.2013Oct24;222(2):212-23.
5.XiMY,SunZY,SunHP,JiaJM,JiangZY,TaoL,YeM,YangX,WangYJ,XueX,HuangJJ,GaoY,GuoXK,ZhangSL,YangYR,GuoQL,HuR*,YouQD.Synthesisandbioevaluationofaseriesofα-pyronederivativesaspotentactivatorsofNrf2/AREpathway(partI).EurJMedChem.2013Aug;66:364-71.
6.YaoJ,HuR,SunJ,LinB,ZhaoL,ShaY,YouQD,YanT,GuoQL.OroxylinApreventsinflammation-relatedtumorthroughdown-regulationofinflammatorygeneexpressionbyinhibitingNF-κBsignaling.MolCarcinog.2012Sep4.[Epubaheadofprint]
7.HuR,ChenN,YaoJ,ZhaoQ,ZhangF,LiZY,YouQD,GuoQL.TheroleofNrf2andapoptoticsignalingpathwaysinoroxylinA-mediatedresponsesinHCT-116colorectaladenocarcinomacellsandxenografttumors.AnticancerDrugs.2012Jul;23(6):651-8.
8.HuR,SawC,YuR,KongAN.RegulationofNF-E2-relatedfactor2SignalingforCancerChemoprevention:AntioxidantCoupledwithAnti-inflammatory.AntioxidRedoxSign.2010Dec1;13(11):1679-98.